Physical Activity as an Effective Therapeutic Strategy for Improving Psychosocial Outcomes in Children and Adolescents

A studyopens in new tab/window in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP)opens in new tab/window, published by Elsevier, found that physical activity (PA) interventions are effective in reducing psychological symptoms across diverse populations of children and adolescents, including those with various clinical conditions such as attention-deficit/hyperactivity disorder (ADHD), cancer, depression, and obesity.

The researchers conducted an umbrella review, a type of systematic review that attempts to summarize the findings of prior meta-analyses on the breadth of impact of a particular intervention, or a comparison of different intervention for a particular condition. In this umbrella review, the authors summarized the evidence from 18 meta-analyses to assess the efficacy of physical activity (PA) interventions on psychosocial outcomes in children and adolescents struggling with different conditions, including attention-deficit/hyperactivity disorder, cancer, cerebral palsy, chronic respiratory diseases, depression, neuromotor impairment, and obesity.

Drawing from these 18 meta-analyses, the authors compiled data from 118 studies with a total of 21,232 children and adolescent participants. The authors found that PA interventions had small effects on psychosocial outcomes, but that many of the included studies were of low to moderate quality, limiting their ability to make definitive conclusions.

The research team emphasized the importance of including psychosocial outcomes in future randomized studies of PA interventions in children and adolescents, regardless of their physical and psychological conditions or disability. This study adds valuable insights to the ongoing discourse on the role of physical activity in promoting psychosocial well-being in younger populations.

Notes for editors

The article is "Umbrella Systematic Review and Meta-analysis: Physical Activity as an Effective Therapeutic Strategy for Improving Psychosocial Outcomes in Children and Adolescents," by Marianna Purgato, PsyD, PhD, Camilla Cadorin, PhD, candidate, Eleonora Prina, PhD, candidate, Madalena Cabral Ferreira, MD, Lidia Del Piccolo, PhD, Markus Gerber, PhD, Mark J.D. Jordans, PhD, Giovanni Ostuzzi, MD, PhD, Justin Richards, PhD, Doriana Rudi, MSc, Francesca Vitali, PhD, Samuele Cortese, MD, PhD, Federico Schena, MD, PhD, Corrado Barbui, MD (https://doi.org/10.1016/j.jaac.2023.04.017). It appears in Journal of the American Academy of Child & Adolescent Psychiatry, volume 63 issue 2 (February 2024), published by Elsevier.

Copies of this paper are available to credentialed journalists upon request; please contact Marianna Purgato, PhD at [email protected].

About JAACAP

Journal of the American Academy of Child and Adolescent Psychiatryopens in new tab/window (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.

The Journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The Journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.